Page 5,004«..1020..5,0035,0045,0055,006..5,0105,020..»

hESC Products Market: Human Embryonic Stem Cell Patent IP Landscape Opportunity Analysis in New Research Report

Posted: Published on August 3rd, 2013

DALLAS, Aug. 2, 2013 /PRNewswire-iReach/ -- This market research report explores the complex IP landscape affecting development of human embryonic stem cell products, providing clear guidance for companies entering or already within the market, from collaborating with WARF to less costly alternatives - such as circumventing the claims, conducting research off-shore, and developing embryonic stem cell products for other species. The report also gives you a wealth of valuable market data to ensure you develop and market products in this stem cell sector effectively. Understand historical and future growth projections, view competitive analysis of providers of hESC research tools and a breakdown of product categories. Learn this and much more in this leading 133-page market intelligence report "Opportunities in Human Embryonic Stem Cell Products" @ http://www.reportsnreports.com/reports/10600-opportunities-in-human-embryonic-stem-cell-hesc-products.html. This report will help you understand the market entry challenges you face and give you the expert advice to overcome the patent IP structure of the industry. Couple this with market leading intelligence data and this report is a must have if you're looking to outcompete your rivals in this expanding and highly profitable market. (Photo: http://photos.prnewswire.com/prnh/20130802/MN57791) The major reason for offering this report with up-to-date data and information is to guide biotechnology and … Continue reading

Posted in Stem Cell Research | Comments Off on hESC Products Market: Human Embryonic Stem Cell Patent IP Landscape Opportunity Analysis in New Research Report

3 questions about stem cells and osteoarthritis – Video

Posted: Published on August 3rd, 2013

3 questions about stem cells and osteoarthritis http://www.stemcellsarthritistreatment.com 3 Questions about stem cells and arthritis What types of stem cells are you using for osteoarthritis? Will I need ... By: Nathan Wei … Continue reading

Comments Off on 3 questions about stem cells and osteoarthritis – Video

Stem cell therapy offers hope of eliminating need for heart transplants

Posted: Published on August 3rd, 2013

by KING 5 News KING5.com Posted on August 2, 2013 at 3:24 PM Updated today at 5:47 PM What do singer Randy Travis and Dick Cheney have in common?They both have a device that keeps the heart pumping until a transplant becomes available. But now researchers think that adding stem cells at the same time could eventually make heart transplants obsolete. Allan Isaacs, 71, had congestive heart failure, which made it difficult to perform basic tasks such as walking, breathing and eating. But after getting a left ventricular assist device put in his chest, he got moving again. The LVAD helps pump oxygen-rich blood throughout the body, but Isaccs' recovery may also have to do with the fact that his treatment included injections of his own bone marrow stem cells. Isaacs is taking part in a cutting-edge study at the University of Minnesota. "We isolate the stem cells and when they go in for surgery we inject those cells on the heart wall," said Dr.Ganesh Raveendran, director of the Cardiac Catheterization Laboratory at the University of Minnesota Medical Center. One-third of the patients receive a placebo, and the rest get 10 injections of stem cells into their hearts. Muscle tissue … Continue reading

Comments Off on Stem cell therapy offers hope of eliminating need for heart transplants

How 'junk DNA' can control cell development

Posted: Published on August 3rd, 2013

Researchers have unravelled a previously unknown mechanism for regulating the activity of genes. Researchers from the Gene and Stem Cell Therapy Program at Sydney's Centenary Institute have confirmed that, far from being "junk", the 97 per cent of human DNA that does not encode instructions for making proteins can play a significant role in controlling cell development. And in doing so, the researchers have unravelled a previously unknown mechanism for regulating the activity of genes, increasing our understanding of the way cells develop and opening the way to new possibilities for therapy. Using the latest gene sequencing techniques and sophisticated computer analysis, a research group led by Professor John Rasko AO and including Centenary's Head of Bioinformatics, Dr William Ritchie, has shown how particular white blood cells use non-coding DNA to regulate the activity of a group of genes that determines their shape and function. The work is published today in the scientific journal Cell. "This discovery, involving what was previously referred to as "junk", opens up a new level of gene expression control that could also play a role in the development of many other tissue types," Rasko says. "Our observations were quite surprising and they open entirely new … Continue reading

Comments Off on How 'junk DNA' can control cell development

World-class stem cell centre for Queenstown

Posted: Published on August 3rd, 2013

A world-class research and treatment centre that will specialise in using the bodys own blood cells to heal sports injuries and arthritis is planned for Queenstown within the year according to one of the worlds leading experts on Stem Cell Therapy. Speaking at the New Zealand College of Appearance Medicine Conference in Queenstown yesterday (Thursday August 1), Professor Boyd said Queenstown was at the forefront of Platelet Rich Plasma therapy in the country and was an "obvious choice" to expand into Stem Cell Therapy. Used in the USA for ten years and Australia for five years, Platelet Rich Plasma (PRP) is already available in New Zealand thanks to Queenstown Regenerative Medicine (QRM) an internationally-linked Queenstown clinic. Endorsed worldwide by global sports superstars such as Tiger Woods and Kobe Bryant, PRP is a process by which a small amount of blood is taken from the patient and then spun in a centrifuge which automatically produces PRP (blood plasma with a concentrated amount of platelets). Platelets are the bloods "ambulance, containing over 20 factors important for tissue repair and keeping the body healthy. The process takes about 15 to 20 minutes and increases the concentration of platelets by up to 500%. The … Continue reading

Comments Off on World-class stem cell centre for Queenstown

World-class Stem Cell Research Centre for Queenstown

Posted: Published on August 3rd, 2013

A world-class research and treatment centre that will specialise in using the bodys own blood cells to heal sports injuries and arthritis is planned for Queenstown within the year according to one of the worlds leading experts on Stem Cell Therapy. Speaking at the New Zealand College of Appearance Medicine Conference in Queenstown yesterday (Thursday August 1), Professor Boyd said Queenstown was at the forefront of Platelet Rich Plasma therapy in the country and was an "obvious choice" to expand into Stem Cell Therapy. Used in the USA for ten years and Australia for five years, Platelet Rich Plasma (PRP) is already available in New Zealand thanks to Queenstown Regenerative Medicine (QRM) an internationally-linked Queenstown clinic. Endorsed worldwide by global sports superstars such as Tiger Woods and Kobe Bryant, PRP is a process by which a small amount of blood is taken from the patient and then spun in a centrifuge which automatically produces PRP (blood plasma with a concentrated amount of platelets). Platelets are the bloods "ambulance, containing over 20 factors important for tissue repair and keeping the body healthy. The process takes about 15 to 20 minutes and increases the concentration of platelets by up to 500%. The … Continue reading

Comments Off on World-class Stem Cell Research Centre for Queenstown

World-class Stem Cell Research, Therapy for Queenstown

Posted: Published on August 3rd, 2013

Media release from Queenstown Regenerative Medicine August 2 2013 World-class Stem Cell Research and Therapy Centre for Queenstown A world-class research and treatment centre that will specialise in using the bodys own blood cells to heal sports injuries and arthritis is planned for Queenstown within the year according to one of the worlds leading experts on Stem Cell Therapy. Speaking at the New Zealand College of Appearance Medicine Conference in Queenstown yesterday (Thursday August 1), Professor Boyd said Queenstown was at the forefront of Platelet Rich Plasma therapy in the country and was an obvious choice to expand into Stem Cell Therapy. Used in the USA for ten years and Australia for five years, Platelet Rich Plasma (PRP) is already available in New Zealand thanks to Queenstown Regenerative Medicine (QRM) an internationally-linked Queenstown clinic. Endorsed worldwide by global sports superstars such as Tiger Woods and Kobe Bryant, PRP is a process by which a small amount of blood is taken from the patient and then spun in a centrifuge which automatically produces PRP (blood plasma with a concentrated amount of platelets). Platelets are the bloods ambulance, containing over 20 factors important for tissue repair and keeping the body healthy. The … Continue reading

Comments Off on World-class Stem Cell Research, Therapy for Queenstown

Mac Stem Cell Therapy 2012 – Video

Posted: Published on August 2nd, 2013

Mac Stem Cell Therapy 2012 Before and After Mac's Stem Cell Therapy. Surgery done by Dr. Mark McCloskey, DVM, Columbus, OH. By: Mary Hammond … Continue reading

Comments Off on Mac Stem Cell Therapy 2012 – Video

Cytomedix to Host Second Quarter 2013 Financial Results Conference Call on Thursday, August 8, 2013

Posted: Published on August 2nd, 2013

GAITHERSBURG, MD--(Marketwired - Aug 2, 2013) - Cytomedix, Inc. (OTCQX: CMXI), a regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies, announced today that it will release financial results for the three- and six-month period ended June 30, 2013, after the close of the market on Wednesday, August 7, 2013. The company will host a conference call beginning at 8:00am Eastern time on Thursday, August 8, 2013 to discuss the second quarter results and to answer questions. Participating in the call will be Martin Rosendale, Chief Executive Officer, and Steven Shallcross, Chief Financial Officer. Conference Call & Webcast Thursday, August 8, 2013 @ 8:00am Eastern/5:00am PacificDomestic dial in: 877-280-4960 International: 857-244-7317 Passcode: 37473493 Webcast: http://www.cytomedix.com Replays - Available through August 15, 2013 Domestic: 888-286-8010 International: 617-801-6888 Passcode: 81192539 About Cytomedix:Cytomedix, Inc. is an autologous regenerative therapies company commercializing innovative platelet technologies for orthopedics and wound care with a pipeline of adult stem cell therapies for tissue repair. The Company markets the AutoloGel System, a device for the production of autologous platelet rich plasma ("PRP") gel for use on a variety of exuding wounds and the Angel Concentrated Platelet Rich Plasma System, a blood processing device and … Continue reading

Posted in Stem Cell Human Trials | Comments Off on Cytomedix to Host Second Quarter 2013 Financial Results Conference Call on Thursday, August 8, 2013

StemCells, Inc. Presents Two-Year Pelizaeus-Merzbacher Disease (PMD) Data Suggesting Departure From Natural History of …

Posted: Published on August 2nd, 2013

NEWARK, Calif., Aug. 2, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (STEM) today presented data which show that two years after transplantation of the Company's proprietary HuCNS-SC(R) cells (purified human neural stem cells) into patients with Pelizaeus-Merzbacher disease (PMD), the evidence of myelination, by magnetic resonance imaging (MRI), is more pronounced compared to one year post-transplantation, the gains in neurological function reported after one year were maintained, and there were no safety concerns. Patients with PMD have a defective gene which leads to insufficient myelin in the brain, resulting in progressive loss of neurological function and death. The neurological and MRI changes suggest a departure from the natural history of the disease and may represent signals of a clinical effect. The data was presented today by Stephen Huhn, MD, FACS, FAAP, Vice President, CNS Clinical Research at StemCells, Inc., at the 2013 Pelizaeus-Merzbacher Disease Symposium and Health Fair being held at Nemours/Alfred I. duPont Children's Hospital in Wilmington, Del. "We are encouraged that the MRI data continue to indicate new and durable myelination related to the transplanted cells and that the data is even stronger after two years compared to one year," said Dr. Huhn. "Even in the context of a … Continue reading

Posted in Stem Cell Human Trials | Comments Off on StemCells, Inc. Presents Two-Year Pelizaeus-Merzbacher Disease (PMD) Data Suggesting Departure From Natural History of …

Page 5,004«..1020..5,0035,0045,0055,006..5,0105,020..»